BRSF (Brain Scientific) Ending Cash Position: $0.75 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRSF Brain Scientific Inc BRSF
10 GF Score
Price $0.00
View Full Analysis

What is Brain Scientific Ending Cash Position?

Brain Scientific BRSF 10 Ending Cash Position is $0.75 Mil as of Dec. 2022. GuruFocus rates BRSF with a GF Score™ of 10/100.

Brain Scientific's Ending Cash Position for the quarter that ended in Dec. 2022 was $0.75 Mil.

Brain Scientific's quarterly Ending Cash Position declined from Jun. 2022 ($3.54 Mil) to Sep. 2022 ($2.03 Mil) and declined from Sep. 2022 ($2.03 Mil) to Dec. 2022 ($0.75 Mil).

Brain Scientific's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.79 Mil) but then declined from Dec. 2021 ($0.79 Mil) to Dec. 2022 ($0.75 Mil).

Brain Scientific Ending Cash Position Related Terms

Brain Scientific Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Brain Scientific's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brain Scientific Ending Cash Position Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
Ending Cash Position
0.79 0.75

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Ending Cash Position Get a 7-Day Free Trial 0.79 0.35 3.54 2.03 0.75
BRSF
10GF Score
Brain Scientific Inc BRSF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brain Scientific Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Brain Scientific's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.785+-0.037
=0.75

Brain Scientific's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.03+-1.282
=0.75

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.75 Mil mean?
Brain Scientific (BRSF) has a Ending Cash Position of $0.75 Mil as of Dec. 2022. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Brain Scientific and its competitors.
Is Brain Scientific's Ending Cash Position too high?
Brain Scientific's current Ending Cash Position is $0.75 Mil. Overall, Brain Scientific has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Brain Scientific's Ending Cash Position compare to MOTS and BRSF?
Brain Scientific's Ending Cash Position of $0.75 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Brain Scientific and its competitors. Brain Scientific's current Ending Cash Position is $0.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain Scientific stock overvalued right now?
Brain Scientific (BRSF) has a current Ending Cash Position of $0.75 Mil. The current Ending Cash Position is $0.75 Mil. Brain Scientific's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Brain Scientific (BRSF), the current Ending Cash Position is $0.75 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brain Scientific Business Description

Address 6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
10GF Score

Get the complete analysis for BRSF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price